4//SEC Filing
HARDY REGINALD L 4
Accession 0000911916-20-000143
CIK 0000819050other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 2:01 PM ET
Size
12.5 KB
Accession
0000911916-20-000143
Insider Transaction Report
Form 4
HARDY REGINALD L
DirectorChairman of the Board
Transactions
- Tax Payment
Common Stock
2020-06-30$1.00/sh−283$283→ 196,472 total - Exercise/Conversion
Common Stock
2020-06-30+883→ 196,755 total - Exercise/Conversion
Restricted Stock Units
2020-06-30−883→ 1,765 total→ Common Stock (883 underlying)
Holdings
- 17,260(indirect: By Trust)
Common Stock
- 21,826(indirect: By Spouse)
Common Stock
- 266,447(indirect: By Self as General Partner)
Common Stock
- 9,261(indirect: By Spouse)
Common Stock
- 17,260(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Restricted stock units ("RSUs") converted into common stock on a one-for-one basis.
- [F2]Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs.
- [F3]These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020.
- [F4]The reporting person filed a Form 4 on June 5, 2020 which reported, among other transactions, the vesting on various dates of portions of a grant of RSUs made to the reporting person on February 14, 2020. Column 9 of Table II of that Form 4 incorrectly reported the number of unvested RSUs remaining from that grant following each such vesting. The number reported in this Column 9 of Table II of this Form 4 represents the correct number of unvested RSUs remaining from the February 14, 2020 grant following the vestings that were reported on the Form 4 filed on June 5, 2020, as well as the vesting that occurred on June 30, 2020 as reported on this Form 4.
Documents
Issuer
Brickell Biotech, Inc.
CIK 0000819050
Entity typeother
Related Parties
1- filerCIK 0001008105
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 2:01 PM ET
- Size
- 12.5 KB